Abstract No. 117 A phase 3, double-blind, randomized study of nivolumab and Ipilimumab), nivolumab monotherapy, or placebo plus transarterial chemoembolization in patients with intermediate-stage hepatocellular carcinoma

Randomized Study ◽

Intermediate Stage ◽

Phase 3 ◽

Double Blind

P-107 LEAP-012: A randomized, double-blind, phase 3 study of pembrolizumab plus lenvatinib in combination with transarterial chemoembolization (TACE) in patients with intermediate-stage hepatocellular carcinoma not amenable to curative treatment

Annals of Oncology ◽

10.1016/j.annonc.2020.04.189 ◽

2020 ◽

Vol 31 ◽

pp. S124-S125

Author(s):

S. Ogasawara ◽

J. Llovet ◽

A. El-Khoueiry ◽

A. Vogel ◽

D. Madoff ◽

...

Keyword(s):

Intermediate Stage ◽

Curative Treatment ◽

Phase 3 ◽

Double Blind

P-347 A phase 3, randomized, double-blind, placebo-controlled study of transarterial chemoembolization combined with durvalumab or durvalumab plus bevacizumab therapy in patients with locoregional hepatocellular carcinoma: EMERALD-1

Annals of Oncology ◽

10.1016/j.annonc.2020.04.429 ◽

2020 ◽

Vol 31 ◽

pp. S202-S203 ◽

Cited By ~ 2

Author(s):

B. Sangro ◽

M. Kudo ◽

S. Qin ◽

Z. Ren ◽

S. Chan ◽

...

Keyword(s):

Controlled Study ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(15)00050-9 ◽

2015 ◽

Vol 16 (7) ◽

pp. 859-870 ◽

Cited By ~ 344

Author(s):

Andrew X Zhu ◽

Joon Oh Park ◽

Baek-Yeol Ryoo ◽

Chia-Jui Yen ◽

Ronnie Poon ◽

...

Keyword(s):

Advanced Hepatocellular Carcinoma ◽

Line Treatment ◽

Second Line ◽

First Line ◽

Phase 3 ◽

Double Blind ◽

Multicentre Phase ◽

First Line Therapy ◽

Line Therapy

Intermediate stage hepatocellular carcinoma: Comparison of the value of inflammation-based scores in predicting progression-free survival of patients receiving transarterial chemoembolization

Journal of Cancer Research and Therapeutics ◽

10.4103/jcrt.jcrt_29_21 ◽

2021 ◽

Vol 17 (3) ◽

pp. 740

Author(s):

Weijun Fan ◽

Ying Liu ◽

Menting Shi ◽

Shuanggang Chen ◽

Weiqi Wan ◽

...

Keyword(s):

Progression Free Survival ◽

Intermediate Stage ◽

Free Survival

Phase 3, single-center, sequential and parallel-group, double-blind, randomized study evaluating the efficacy and safety of Fexofenadine Hydrochloride 180 mg (Allegra®/Telfast®) versus placebo in subjects suffering from Allergic Rhinitis with symptoms aggravated in presence of pollutants: analysis of individual symptom scores

World Allergy Organization Journal ◽

10.1016/j.waojou.2020.100266 ◽

2020 ◽

Vol 13 (8) ◽

pp. 100266

Author(s):

Anne K. Ellis ◽

Margarita Murrieta-Aguttes ◽

Sandy Furey ◽

Christopher Carlsten

Keyword(s):

Allergic Rhinitis ◽

Randomized Study ◽

Efficacy And Safety ◽

Single Center ◽

Phase 3 ◽

Double Blind ◽

Parallel Group ◽

Symptom Scores

Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat?

Radiology ◽

10.1148/radiol.2021202289 ◽

2021 ◽

Vol 298 (3) ◽

pp. 680-692

Author(s):

Shuling Chen ◽

Zhenwei Peng ◽

Yaojun Zhang ◽

Minshan Chen ◽

Jiaping Li ◽

...

Keyword(s):

Intermediate Stage

Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study

Frontiers in Oncology ◽

10.3389/fonc.2020.578633 ◽

2020 ◽

Vol 10 ◽

Author(s):

Xiaoyan Ding ◽

Wei Sun ◽

Jinglong Chen ◽

Wei Li ◽

Yanjun Shen ◽

...

Keyword(s):

Radiofrequency Ablation ◽

Randomized Study ◽

Venous System ◽

Prospective Randomized Study ◽

Portal Venous System ◽

Percutaneous Radiofrequency Ablation ◽

System A ◽

Large Hepatocellular Carcinoma

Microvascular Invasion as a Predictor of Response to Treatment with Sorafenib and Transarterial Chemoembolization for Recurrent Intermediate-Stage Hepatocellular Carcinoma

Radiology ◽

10.1148/radiol.2019181818 ◽

2019 ◽

Vol 292 (1) ◽

pp. 237-247 ◽

Cited By ~ 10

Author(s):

Zhenwei Peng ◽

Shuling Chen ◽

Han Xiao ◽

Yu Wang ◽

Jiaping Li ◽

...

Keyword(s):

Intermediate Stage ◽

Microvascular Invasion ◽

Response To Treatment

Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis

BMC Gastroenterology ◽

10.1186/s12876-020-01235-w ◽

2020 ◽

Vol 20 (1) ◽

Cited By ~ 1

Author(s):

Chih-Wen Lin ◽

Yaw-Sen Chen ◽

Gin-Ho Lo ◽

Yao-Chun Hsu ◽

Chia-Chang Hsu ◽

...

Keyword(s):

Overall Survival ◽

Radiofrequency Ablation ◽

Propensity Score ◽

Propensity Score Matching ◽

Surgical Resection ◽

Propensity Score Matching Analysis

Intermediate Stage ◽

Two-Year Results of Envarsus (Once-Daily MeltDose Tacrolimus Tablets) vs Prograf (Twice-Daily Tacrolimus Capsules): A Phase 3, Double-Blind, Double-Dummy, Multi-Center, Prospective, Randomized Study.

Transplantation Journal ◽

10.1097/00007890-201407151-02240 ◽

2014 ◽

Vol 98 ◽

pp. 661-662 ◽

Cited By ~ 1

Author(s):

L. Rostaing ◽

K. Ciechanowski ◽

S. Bunnapradist ◽

H. Silva ◽

J. Grinyo ◽

...

Keyword(s):

Randomized Study ◽

Prospective Randomized Study ◽

Phase 3 ◽

Double Blind ◽

Once Daily